{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T04:41:39Z","timestamp":1771562499956,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0011707","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000}}],"reference-count":38,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T00:00:00Z","timestamp":1699401600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Inosan Biopharma","award":["# 18 07 008-00"],"award-info":[{"award-number":["# 18 07 008-00"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Snakebites is a serious public health issue but remains a neglected tropical disease. Data on antivenom effectiveness are urgently needed in Africa. We assessed effectiveness of Inoserp PAN-AFRICA (IPA), the recommended antivenom available in Cameroon.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methodology\/Principal findings<\/jats:title>\n<jats:p>We enrolled 447 patients presenting with snakebite in 14 health facilities across Cameroon. At presentation, cytotoxicity, coagulation troubles and neurotoxicity were graded. We administered two to four vials of antivenom to patients based on hemotoxic or neurotoxic signs. We renewed antivenom administration to patients with persistence of bleedings or neurotoxicity 2 hours after each injection. We defined early improvement as a reduction of the grade of envenomation symptoms 2 hours after first injection. Medium-term effectiveness was investigated looking at disappearance of symptoms during hospitalization. After hospital discharge, a home visit was planned to assess long-term outcomes.<\/jats:p>\n<jats:p>Between October 2019 and May 2021, we enrolled 447 (93.7%), including 72% from the savannah regions. The median [IQR] age was 25 [14\u201340]. Envenomation was diagnosed in 369 (82.6%) participants. The antivenom was administered to 356 patients (96.5%) of whom 256 (71.9%) received one administration. Among these patients, cytotoxic symptoms were observed in 336 (94.4%) participants, coagulation disorders in 234 (65.7%) participants and neurotoxicity in 23 (6.5%) participants. Two hours after the first administration of antivenom, we observed a decrease in coagulation disorders or neurotoxicity in 75.2% and 39.1% of patients, respectively. Complete cessation of bleedings and neurotoxicity occurred in 96% and 93% of patients within 24 hours, respectively. Sequelae have been observed in 9 (3%) patients at the home visit 15 days after hospital admission and 11 (3%) died including one before antivenom injection.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Conclusions\/Significance<\/jats:title>\n<jats:p>We confirmed good effectiveness of the IPA and highlighted the rapid improvement in bleeding or neurotoxicity after the first administration. Sequential administrations of low doses of antivenom, rigorously assessed at short intervals for an eventual renewal, can preserve patient safety and save antivenom.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Trial registration<\/jats:title>\n<jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03326492\" xlink:type=\"simple\">NCT03326492<\/jats:ext-link>.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pntd.0011707","type":"journal-article","created":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T18:48:55Z","timestamp":1699469335000},"page":"e0011707","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["Real life condition evaluation of Inoserp PAN-AFRICA antivenom effectiveness in Cameroon"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1976-8568","authenticated-orcid":true,"given":"Jean-Philippe","family":"Chippaux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigue","family":"Ntone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Benhammou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoann","family":"Madec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ga\u00eblle","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anais","family":"Perilhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fai","family":"Karl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Amta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucrece","family":"Matchim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Clauteaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucr\u00e8ce","family":"Eteki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Ndifon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yap","family":"Boum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armand S.","family":"Nkwescheu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,11,8]]},"reference":[{"key":"pntd.0011707.ref001","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s40409-017-0127-6","article-title":"Snakebite envenomation turns again into a neglected tropical disease!","volume":"23","author":"JP Chippaux","year":"2017","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"pntd.0011707.ref002","doi-asserted-by":"crossref","first-page":"e20190083","DOI":"10.1590\/1678-9199-jvatitd-2019-0083","article-title":"The WHO strategy for prevention and control of snakebite envenoming: a sub-Saharan Africa plan","volume":"25","author":"JP Chippaux","year":"2019","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"issue":"4","key":"pntd.0011707.ref003","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.toxicon.2010.12.022","article-title":"Estimate of the burden of snakebites in sub-Saharan Africa: a meta-analytic approach","volume":"57","author":"JP Chippaux","year":"2011","journal-title":"Toxicon"},{"issue":"12","key":"pntd.0011707.ref004","doi-asserted-by":"crossref","first-page":"e569","DOI":"10.1371\/journal.pntd.0000569","article-title":"Snake envenoming: a disease of poverty","volume":"3","author":"RA Harrison","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"pntd.0011707.ref005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nbt0207-173","article-title":"Bringing antivenoms to Sub-Saharan Africa","volume":"25","author":"RP Stock","year":"2007","journal-title":"Nat Biotechnol"},{"issue":"1","key":"pntd.0011707.ref006","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1186\/s12889-019-7363-3","article-title":"High snakebite underreporting rate in the Centre Region of Cameroon: an observational study","volume":"19","author":"D Tchoffo","year":"2019","journal-title":"BMC Public Health"},{"issue":"6","key":"pntd.0011707.ref007","doi-asserted-by":"crossref","first-page":"e0009464","DOI":"10.1371\/journal.pntd.0009464","article-title":"Health and economic burden estimates of snakebite management upon health facilities in three regions of southern Burkina Faso","volume":"15","author":"S Ahmed","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"pntd.0011707.ref008","doi-asserted-by":"crossref","first-page":"e0004088","DOI":"10.1371\/journal.pntd.0004088","article-title":"Snakebite is Under Appreciated: Appraisal of Burden from West Africa","volume":"9","author":"AG Habib","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0011707.ref009","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxicon.2018.12.002","article-title":"Snakebite burden in Sub-Saharan Africa: estimates from 41 countries","volume":"159","author":"S Halilu","year":"2019","journal-title":"Toxicon"},{"issue":"12","key":"pntd.0011707.ref010","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/trstmh\/trv088","article-title":"Antivenom shortage is not circumstantial but structural","volume":"109","author":"JP Chippaux","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"10010","key":"pntd.0011707.ref011","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0140-6736(15)01104-6","article-title":"Snake bites and antivenom shortage in Africa","volume":"386","author":"JP Chippaux","year":"2015","journal-title":"Lancet"},{"issue":"8","key":"pntd.0011707.ref012","doi-asserted-by":"crossref","first-page":"e0008374","DOI":"10.1371\/journal.pntd.0008374","article-title":"Challenges and prospects of snake antivenom supply in sub-Saharan Africa","volume":"14","author":"AG Habib","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0011707.ref013","doi-asserted-by":"crossref","first-page":"e0007551","DOI":"10.1371\/journal.pntd.0007551","article-title":"Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial","volume":"13","author":"J Potet","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"pntd.0011707.ref014","first-page":"56","article-title":"Evaluation of a new polyvalent antivenom against snakebite envenomation (Inoserp(R) Panafricain) in two different epidemiological settings: Northern Benin and Maritime Guinea","volume":"25","author":"JP Chippaux","year":"2015","journal-title":"Med Sante Trop"},{"issue":"1","key":"pntd.0011707.ref015","first-page":"18","article-title":"Evaluation of the efficacy and tolerance of Inoserp (R) Panafricain in Senegal","volume":"31","author":"A Lam","year":"2019","journal-title":"Toxicol Anal Clin"},{"issue":"7","key":"pntd.0011707.ref016","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.toxicon.2010.02.022","article-title":"Methodology of clinical studies dealing with the treatment of envenomation","volume":"55","author":"JP Chippaux","year":"2010","journal-title":"Toxicon"},{"key":"pntd.0011707.ref017","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.toxicon.2013.07.014","article-title":"Effectiveness of Centruroides scorpion antivenom compared to historical controls","volume":"76","author":"LV Boyer","year":"2013","journal-title":"Toxicon"},{"issue":"6","key":"pntd.0011707.ref018","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0035-9203(98)90802-1","article-title":"Clinical safety of a polyvalent F(ab\u2019)2 equine antivenom in 223 African snake envenomations: a field trial in Cameroon. VAO (Venin Afrique de l\u2019Ouest) Investigators","volume":"92","author":"JP Chippaux","year":"1998","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"11","key":"pntd.0011707.ref019","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0041-0101(91)90116-9","article-title":"Snake venom variability: methods of study, results and interpretation","volume":"29","author":"JP Chippaux","year":"1991","journal-title":"Toxicon"},{"key":"pntd.0011707.ref020","unstructured":"WHO. World Health Organization. Expert Committee on Biological Standardization, 67th report. http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255657\/9789241210133-eng.pdf?sequence=1&isAllowed=y#page=217. Accessed on July 2023. WHO technical report series. 2017;1004:197\u2013353."},{"key":"pntd.0011707.ref021","unstructured":"WHO. World Health Organization. Guidelines for the prevention and clinical management of snakebite in Africa. https:\/\/apps.who.int\/iris\/handle\/10665\/204458. Accessed on July 2023. 2010:145."},{"issue":"3","key":"pntd.0011707.ref022","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4269\/ajtmh.2007.77.538","article-title":"Clinical trial of an F(ab\u2019)2 polyvalent equine antivenom for African snake bites in Benin","volume":"77","author":"Investigators of African Antivipmyn in B","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0011707.ref023","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: Building an international community of software platform partners","volume":"95","author":"PA Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"pntd.0011707.ref024","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"PA Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"pntd.0011707.ref025","first-page":"311","article-title":"\"Faune et flore tropicales\". Les serpents d\u2019Afrique Occidentale et Centrale","volume":"35","author":"JP Chippaux","year":"2006","journal-title":"IRD, Paris, coll"},{"key":"pntd.0011707.ref026","doi-asserted-by":"crossref","DOI":"10.1353\/book.66158","volume-title":"Snakes from Central & Western Africa","author":"JP Chippaux","year":"2019"},{"key":"pntd.0011707.ref027","doi-asserted-by":"crossref","unstructured":"Chippaux JP. Snakebite in Africa: Current situation and urgent needs. In Handbook of Venoms and Toxins of Reptiles, Mckessy SP Ed, Taylor & Francis, CRC Press, Boca Raton, 2nd edition. 2021:593\u2013611.","DOI":"10.1201\/9780429054204-44"},{"issue":"6","key":"pntd.0011707.ref028","doi-asserted-by":"crossref","first-page":"e0008334","DOI":"10.1371\/journal.pntd.0008334","article-title":"Snakebite epidemiology and health-seeking behavior in Akonolinga health district, Cameroon: Cross-sectional study","volume":"14","author":"G Alcoba","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0011707.ref029","doi-asserted-by":"crossref","first-page":"100072","DOI":"10.1016\/j.toxcx.2021.100072","article-title":"Dealing with snakebite in rural Cameroon: A qualitative investigation among victims and traditional healers","volume":"9\u201310","author":"M Chuat","year":"2021","journal-title":"Toxicon X"},{"issue":"4","key":"pntd.0011707.ref030","first-page":"283","article-title":"Impact of snakebites in rural environment: community survey in the rural development community (DRC) of Frilguiagbe, Republic of Guinea","volume":"98","author":"MC Balde","year":"2005","journal-title":"Bull Soc Pathol Exot"},{"issue":"4","key":"pntd.0011707.ref031","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1055\/s-0030-1254053","article-title":"Snakebite doesn\u2019t cause disseminated intravascular coagulation: coagulopathy and thrombotic microangiopathy in snake envenoming","volume":"36","author":"GK Isbister","year":"2010","journal-title":"Semin Thromb Hemost"},{"issue":"6","key":"pntd.0011707.ref032","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jprot.2008.10.003","article-title":"Combined snake venomics and venom gland transcriptomic analysis of the ocellated carpet viper, Echis ocellatus","volume":"71","author":"SC Wagstaff","year":"2009","journal-title":"J Proteomics"},{"issue":"5","key":"pntd.0011707.ref033","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/0041-0101(84)90152-1","article-title":"The Gaboon viper (Bitis gabonica): its biology, venom components and toxinology","volume":"22","author":"NA Marsh","year":"1984","journal-title":"Toxicon"},{"issue":"6","key":"pntd.0011707.ref034","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4269\/ajtmh.1999.61.1017","article-title":"Short report: treatment of snake envenomations by a new polyvalent antivenom composed of highly purified F(ab)2: results of a clinical trial in northern Cameroon","volume":"61","author":"JP Chippaux","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0011707.ref035","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/MBC.0000000000000702","article-title":"Thromboelastographic study of the snakebite-related coagulopathy in Djibouti","volume":"29","author":"S Larreche","year":"2018","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"2","key":"pntd.0011707.ref036","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ajem.2009.08.022","article-title":"Antivenin remains effective against African Viperidae bites despite a delayed treatment","volume":"29","author":"S Larreche","year":"2011","journal-title":"Am J Emerg Med"},{"issue":"3","key":"pntd.0011707.ref037","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1160\/TH16-10-0769","article-title":"Performance of the 20-minute whole blood clotting test in detecting venom induced consumption coagulopathy from Russell\u2019s viper (Daboia russelii) bites","volume":"117","author":"I Ratnayake","year":"2017","journal-title":"Thromb Haemostasis"},{"issue":"2","key":"pntd.0011707.ref038","first-page":"109","article-title":"Diagnosis and monitoring of hemorrhage due to viper envenomation in the African savanna","volume":"92","author":"JP Chippaux","year":"1999","journal-title":"Bull Soc Pathol Exot"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0011707","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T00:00:00Z","timestamp":1700438400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T18:48:53Z","timestamp":1700506133000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0011707"}},"subtitle":[],"editor":[{"given":"Manuela","family":"Pucca","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,11,8]]},"references-count":38,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,11,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0011707","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0011707","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,8]]}}}